Cantor Fitzgerald’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-450
Closed -$231K 684
2022
Q4
$231K Sell
450
-5
-1% -$2.54K 0.01% 555
2022
Q3
$207K Sell
455
-455
-50% -$218K ﹤0.01% 598
2022
Q2
$440K Buy
+910
New +$450K 0.01% 563

Other funds holding ELV

Cantor Fitzgerald's ELV Position: Q1 2023 in Review

Cantor Fitzgerald sold out of Elevance Health (ELV) in Q1 2023, closing a stake of 450 shares — an estimated $231K sold.

Cantor Fitzgerald first reported a position in ELV in Q2 2022 and held it in 3 quarters. The position peaked at $440K in Q2 2022. 1,516 funds tracked by Wall St. Rank hold ELV as of Q1 2023.

  • Cantor Fitzgerald reported no remaining Elevance Health position as of Q1 2023 after selling out during the quarter.
  • Cantor Fitzgerald sold 450 Elevance Health shares in Q1 2023, an estimated $231K.
  • Cantor Fitzgerald first reported a position in Elevance Health in Q2 2022 and held it in 3 quarters.
  • Cantor Fitzgerald's Elevance Health position peaked at $440K in Q2 2022.
  • 1,516 funds tracked by Wall St. Rank held Elevance Health as of Q1 2023.

Based on Cantor Fitzgerald's 13F filing for Q1 2023, filed 15 May 2023.